Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.
Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Medicine name : Epcoritamab
Generic name : Epkinly
Manufactured By : Genmab
Indications : Relapsed/Refractory Follicular Lymphoma
Medicine Description : A targeted immunotherapy for relapsed or refractory follicular lymphoma, Epcoritamab (Epkinly) is a bispecific T-cell engager antibody that targets CD3 on T cells and CD20 on B cells, enabling the immune system to recognize and destroy malignant B cells. It is used in patients whose disease has progressed after multiple prior therapies. Administered via subcutaneous injection, it offers a novel immune-based treatment approach. Common side effects include cytokine release syndrome, fatigue, fever, injection-site reactions, and infections. Close monitoring is required, particularly during initial doses, to manage immune-related adverse events.